Method of treating atherosclerosis, dyslipidemias and related conditions and pharmaceutical compositions

Details for Australian Patent Application No. 2012233008 (hide)

Owner Merck Frosst Canada Ltd Merck Sharp & Dohme Corp

Inventors Cheng, Kang; Waters, Gerard; Metters, Kathleen; O'Neill, Gary

Agent AJ Park

Pub. Number AU-A-2012233008

Parent 2011200986

Filing date 2 October 2012

Wipo publication date 1 November 2012

International Classifications

A61K 31/455 - Nicotinic acid, i.e. niacin

A61K 31/00

A61K 31/403 - condensed with carbocyclic rings, e.g. carbazole

A61K 31/437

A61K 31/4745

A61K 31/538

A61K 31/69 - Boron compounds

A61P 3/06 Drugs for disorders of the metabolism

Event Publications

18 October 2012 Complete Application Filed

1 November 2012 Application Open to Public Inspection

  Published as AU-A-2012233008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012233009-Reversible shoes / footwear

2012233007-An Artificial Reef